1Nnoaham KE,Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analyses[J]. Int J Epidemiol, 2008,37 ( 1 ) : 113-119.
2Rathored J,Sharma SK, Singh B, et al. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25 (OH) D [J]. Int J Tuberc Lung Dis, 2012,16 (11) : 1522-1528.
3Martineau AR, Honecker FU, Wilkinson RJ, et al. Vita- min D in the treatment of pulmonary tuberculosis [J]. J Steroid Biochem Mol Biol, 2007,103(3): 793-798.
4Zehnder D, Bland R, Williams MC, et al. Extrarenal ex- pression of 25-hydroxyvitamin d (3)-1 alpha-hydroxylase I-J]. Clinb Endocrinol Metab, 2001,86 (2) : 888-894.
5Maruotti N, Cantatore FP. Vitamin D and the immune systemJ-J:. Rheumatology,2010,37(3) :491-495.
7Liu PT, Stenger S, Li H, et al. Toll-like receptor trigge- ring of a vitamin D-mediated human antimicrobial re- sponse[J]. Science,2006,311(5768) :1770-1773.
8Liu PT, Stenger S, Tang DH, et al. Cutting edge: vitamin D-mediated human antimicrobial activity against Myco- bacterium tuberculosis is dependent on the induction of cathelicidin[J]. Immunology, 2007,179 (4) : 2060-2063.
4Holick MF. Vitamin D : its role in cancer prevention and treatment [J]. Prog Biophys Mol Biol,2006,92( 1 ) :49 -59.
5Miller EH. Vitamin D insufficiency in male osteoporosis [ J ]. Clin Cornerstone,2006,8 Suppl 3 :s14 - s18.
6Lagishetty V, Liu NQ, Hewison M. Vitamin D metabolism and innate immunity[ J]. Mol Cell Endocrinol,2011,347( 1 -2) :97 - 105.
7Kreutz M, Androesen R, Krause SW, et al. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmen- tallyregulated during differentiation of human monocytes into macro- phages [ J ]. Blood, 1993,82 (4) : 1300 - 1307.
8Koofller HP, Reichel H, Bishop JE, et al. gamma-Interferon stimu- lates production of 1,25-dihydroxyvitamin D3 by normal human- macrophages[ J ]. Biochem Biophys Res Commun, 1985,127 (2): 596 - 603.
9Liu PT,Stenger S,Li H,et al. Toll-like receptor triggering of a vita- min D-mediated human antimicrobial response [ J ]. Science, 2006, 311 (5768) :1770 - 1773.
10Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases [ J ]. hat Immunopharmacol, 2002,2 ( 7 ) : 1017 - 1028.
4Jorde R,Grimnes G. Vitamin D and metabolic health with specialreference to the effect of vitamin D on serum lipidsf J]. Prog LipidRes,2011,50(4) :303-312.
5Hewison M. Vitamin D and the intracrinology of innate immunity [J ].Mol Cell Endocrinol,2010,321(2) :103-111.
6Alvarez-Rodriguez L,Lopez-Hoyos M,Garcia-Unzueta M,et al. Ageand low levels of circulating vitamin D are associated with impairedinnate immune function [ J ]. J Leukoc Biol, 2012, 91 ( 5 ):829-838.
7Dickie U,Church LD,Coulthard LR,et al. Vitamin D3 down-regu-lates intracellular Toll-like receptor 9 expression and Toll-likereceptor 9-induced IL-6 production in human monocytes [ J ].Rheumatology (Oxford) ,2010,49(8) : 1466-1471.
8Almerighi C,Sinistro A,Cavazza A,ei al. 1 Alpha,25-dihydroxyvi-tamin D3 inhibits CD40L-induced pro-inflammatory and immuno-modulatory activity in human monocytes [ J ]. Cytokine,2009,45(3):190-197.
9Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentiallycontrol human monocyte antimicrobial responses by regulating vita-min D metabolism [ J ]. Proc Natl Acad Sci U S A ,2010,107 (52):22593-22598.
10Chen S, Sims GP, Chen XX. Modulatory effects of 1 25-dihydroxyvitamin D3 on human B cell differentiation[ J]. J Immu-nol,2007 ,179(3) :1634-1647.
